Global Transdermal Drug Delivery System Market 2017 by Manufacturers, Countries, Forecast to 2022

The Transdermal Drug Delivery System Research Report describe Industry Introduction, Product Scope, Market Overview, Opportunities, Market Risk, Driving Force. Global Market analyze by top manufacturers, by regions, by type and application. The report will include the qualitative and quantitative analysis with market estimation over 2018 – 2023 and compound annual growth rate (CAGR) between 2017 and 2022.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Scope of the Report:
This report focuses on the Transdermal Drug Delivery System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other

Market Segment by Applications, can be divided into
OTC
Rx

There are 15 Chapters to deeply display the global Transdermal Drug Delivery System market.

Chapter 1, to describe Transdermal Drug Delivery System Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Transdermal Drug Delivery System, with sales, revenue, and price of Transdermal Drug Delivery System, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Transdermal Drug Delivery System, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Transdermal Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Transdermal Drug Delivery System sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

1 Market Overview
1.1 Transdermal Drug Delivery System Introduction
1.2 Market Analysis by Type
1.2.1 Fentanyl
1.2.2 Nitroglycerin
1.2.3 Estradiol
1.2.4 Nicotine
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 OTC
1.3.2 Rx
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Business Overview
2.1.2 Transdermal Drug Delivery System Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Transdermal Drug Delivery System Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Mylan Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Transdermal Drug Delivery System Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 GSK Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Transdermal Drug Delivery System Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novartis Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teve (Actavis)
2.5.1 Business Overview
2.5.2 Transdermal Drug Delivery System Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Transdermal Drug Delivery System Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Lohmann
2.7.1 Business Overview
2.7.2 Transdermal Drug Delivery System Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Lohmann Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teikoku Seiyaku
2.8.1 Business Overview
2.8.2 Transdermal Drug Delivery System Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer
2.9.1 Business Overview
2.9.2 Transdermal Drug Delivery System Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Bayer Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lingrui
2.10.1 Business Overview
2.10.2 Transdermal Drug Delivery System Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Lingrui Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sanofi
2.11.1 Business Overview
2.11.2 Transdermal Drug Delivery System Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Sanofi Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Qizheng
2.12.1 Business Overview
2.12.2 Transdermal Drug Delivery System Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Qizheng Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Endo
2.13.1 Business Overview
2.13.2 Transdermal Drug Delivery System Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Endo Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Huarun 999
2.14.1 Business Overview
2.14.2 Transdermal Drug Delivery System Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Huarun 999 Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Haw Par
2.15.1 Business Overview
2.15.2 Transdermal Drug Delivery System Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Haw Par Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Nichiban
2.16.1 Business Overview
2.16.2 Transdermal Drug Delivery System Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Nichiban Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Mentholatum Company
2.17.1 Business Overview
2.17.2 Transdermal Drug Delivery System Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Mentholatum Company Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Laboratoires Genevrier
2.18.1 Business Overview
2.18.2 Transdermal Drug Delivery System Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Transdermal Drug Delivery System Market Competition, by Manufacturer
3.1 Global Transdermal Drug Delivery System Sales and Market Share by Manufacturer
3.2 Global Transdermal Drug Delivery System Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Transdermal Drug Delivery System Manufacturer Market Share
3.3.2 Top 6 Transdermal Drug Delivery System Manufacturer Market Share
3.4 Market Competition Trend

4 Global Transdermal Drug Delivery System Market Analysis by Regions
4.1 Global Transdermal Drug Delivery System Sales, Revenue and Market Share by Regions
4.1.1 Global Transdermal Drug Delivery System Sales by Regions (2012-2017)
4.1.2 Global Transdermal Drug Delivery System Revenue by Regions (2012-2017)
4.2 North America Transdermal Drug Delivery System Sales and Growth (2012-2017)
4.3 Europe Transdermal Drug Delivery System Sales and Growth (2012-2017)
4.4 Asia-Pacific Transdermal Drug Delivery System Sales and Growth (2012-2017)
4.5 South America Transdermal Drug Delivery System Sales and Growth (2012-2017)
4.6 Middle East and Africa Transdermal Drug Delivery System Sales and Growth (2012-2017)

5 North America Transdermal Drug Delivery System by Countries
5.1 North America Transdermal Drug Delivery System Sales, Revenue and Market Share by Countries
5.1.1 North America Transdermal Drug Delivery System Sales by Countries (2012-2017)
5.1.2 North America Transdermal Drug Delivery System Revenue by Countries (2012-2017)
5.2 USA Transdermal Drug Delivery System Sales and Growth (2012-2017)
5.3 Canada Transdermal Drug Delivery System Sales and Growth (2012-2017)
5.4 Mexico Transdermal Drug Delivery System Sales and Growth (2012-2017)

6 Europe Transdermal Drug Delivery System by Countries
6.1 Europe Transdermal Drug Delivery System Sales, Revenue and Market Share by Countries
6.1.1 Europe Transdermal Drug Delivery System Sales by Countries (2012-2017)
6.1.2 Europe Transdermal Drug Delivery System Revenue by Countries (2012-2017)
6.2 Germany Transdermal Drug Delivery System Sales and Growth (2012-2017)
6.3 UK Transdermal Drug Delivery System Sales and Growth (2012-2017)
6.4 France Transdermal Drug Delivery System Sales and Growth (2012-2017)
6.5 Russia Transdermal Drug Delivery System Sales and Growth (2012-2017)
6.6 Italy Transdermal Drug Delivery System Sales and Growth (2012-2017)

7 Asia-Pacific Transdermal Drug Delivery System by Countries
7.1 Asia-Pacific Transdermal Drug Delivery System Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Transdermal Drug Delivery System Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Transdermal Drug Delivery System Revenue by Countries (2012-2017)
7.2 China Transdermal Drug Delivery System Sales and Growth (2012-2017)
7.3 Japan Transdermal Drug Delivery System Sales and Growth (2012-2017)
7.4 Korea Transdermal Drug Delivery System Sales and Growth (2012-2017)
7.5 India Transdermal Drug Delivery System Sales and Growth (2012-2017)
7.6 Southeast Asia Transdermal Drug Delivery System Sales and Growth (2012-2017)

8 South America Transdermal Drug Delivery System by Countries
8.1 South America Transdermal Drug Delivery System Sales, Revenue and Market Share by Countries
8.1.1 South America Transdermal Drug Delivery System Sales by Countries (2012-2017)
8.1.2 South America Transdermal Drug Delivery System Revenue by Countries (2012-2017)
8.2 Brazil Transdermal Drug Delivery System Sales and Growth (2012-2017)
8.3 Argentina Transdermal Drug Delivery System Sales and Growth (2012-2017)
8.4 Columbia Transdermal Drug Delivery System Sales and Growth (2012-2017)

9 Middle East and Africa Transdermal Drug Delivery System by Countries
9.1 Middle East and Africa Transdermal Drug Delivery System Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Transdermal Drug Delivery System Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Transdermal Drug Delivery System Revenue by Countries (2012-2017)
9.2 Saudi Arabia Transdermal Drug Delivery System Sales and Growth (2012-2017)
9.3 UAE Transdermal Drug Delivery System Sales and Growth (2012-2017)
9.4 Egypt Transdermal Drug Delivery System Sales and Growth (2012-2017)
9.5 Nigeria Transdermal Drug Delivery System Sales and Growth (2012-2017)
9.6 South Africa Transdermal Drug Delivery System Sales and Growth (2012-2017)

10 Global Transdermal Drug Delivery System Market Segment by Type
10.1 Global Transdermal Drug Delivery System Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Transdermal Drug Delivery System Sales and Market Share by Type (2012-2017)
10.1.2 Global Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
10.2 Fentanyl Sales Growth and Price
10.2.1 Global Fentanyl Sales Growth (2012-2017)
10.2.2 Global Fentanyl Price (2012-2017)
10.3 Nitroglycerin Sales Growth and Price
10.3.1 Global Nitroglycerin Sales Growth (2012-2017)
10.3.2 Global Nitroglycerin Price (2012-2017)
10.4 Estradiol Sales Growth and Price
10.4.1 Global Estradiol Sales Growth (2012-2017)
10.4.2 Global Estradiol Price (2012-2017)
10.5 Nicotine Sales Growth and Price
10.5.1 Global Nicotine Sales Growth (2012-2017)
10.5.2 Global Nicotine Price (2012-2017)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2012-2017)
10.6.2 Global Other Price (2012-2017)

11 Global Transdermal Drug Delivery System Market Segment by Application
11.1 Global Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
11.2 OTC Sales Growth (2012-2017)
11.3 Rx Sales Growth (2012-2017)

12 Transdermal Drug Delivery System Market Forecast (2017-2022)
12.1 Global Transdermal Drug Delivery System Sales, Revenue and Growth Rate (2017-2022)
12.2 Transdermal Drug Delivery System Market Forecast by Regions (2017-2022)
12.2.1 North America Transdermal Drug Delivery System Market Forecast (2017-2022)
12.2.2 Europe Transdermal Drug Delivery System Market Forecast (2017-2022)
12.2.3 Asia-Pacific Transdermal Drug Delivery System Market Forecast (2017-2022)
12.2.4 South America Transdermal Drug Delivery System Market Forecast (2017-2022)
12.2.5 Middle East and Africa Transdermal Drug Delivery System Market Forecast (2017-2022)
12.3 Transdermal Drug Delivery System Market Forecast by Type (2017-2022)
12.4 Transdermal Drug Delivery System Market Forecast by Application (2017-2022)

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?